Create your personal profile and easily find a job you love.
Sign upAdaptimmune, a leader in T-cell therapy, is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary SPEAR T-cell receptor platform to treat solid tumors, which has the potential to transform the treatment of cancer.
Our proprietary SPEAR T-cell platform has generated a strong pipeline of affinity-enhanced T-cell therapies, with multiple INDs open. We use these...
Adaptimmune, a leader in T-cell therapy, is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary SPEAR T-cell receptor platform to treat solid tumors, which has the potential to transform the treatment of cancer.
Our proprietary SPEAR T-cell platform has generated a strong pipeline of affinity-enhanced T-cell therapies, with multiple INDs open. We use these...
This company page was generated automatically and therefore features only limited information. Find out more about Adaptimmune on their company website:
When you connect, your chance of being approached for an opportunity at this company is 3 times higher.
View what's on offer:
Change language to: Dutch
This page is optimised for people from the UK. View the version optimised for people from the Netherlands.